Evidence map›Paper›PMID 41341895›Full record

ArticleEuropean journal of radiology open2025

Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) for ablation of osteoid osteoma: Long-term results from 10 years of experience.

Francesco Arrigoni, Federico Bruno, Pierpaolo Palumbo, Luigi Rinvenuto, Mario Muselli, Roberto Calbi, Carmine Zoccali, Luigi Zugaro, Alessandra Splendiani, Antonio Barile and 1 more

Abstract read
In one paragraph

Article in European journal of radiology open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Francesco ArrigoniDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Federico BrunoUOC Neuroradiology, San Salvatore Hospital, L'Aquila, Italy.
Pierpaolo PalumboUOC Radiology, San Salvatore Hospital, L'Aquila, Italy.
Luigi RinvenutoDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Mario MuselliDepartment of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
Roberto CalbiF. Miulli General Hospital, Acquaviva Delle Fonti, Bari, Italy.
Carmine ZoccaliOncological Orthopedics, University "Sapienza" of Rome, Italy.
Luigi ZugaroUOC Interventional and Diagnostic Radiology, Ospedale SS Filippo e Nicola, Avezzano, Italy.
Alessandra SplendianiDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Antonio BarileDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Ernesto Di CesareDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoid Osteoma (OO) is a benign but extremely painful bone lesion, mostly treated using Radiofrequency Ablation with needle (RFA). Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) is an alternative technique able to ablate without using needles or skin incisions. Given the scarcity of literature in this field, the purpose of this paper is to retrospectively analyze long-term results of MRgFUS treatments of OO and to investigate technical limits. This is a retrospective analysis of all the MRgFUS procedures performed in our institution to treat OOs. Demographic, clinical data, and morphological features were analyzed, looking for correlation between the clinical results and the morphological features. Sixty-seven procedures were analyzed. The success rate - intended as complete pain relief - was 91 %. Almost all the patients (60 out of 67) were followed up to 4 years. A thick bone cortex above the nidus (p.014) and a short distance between the nidus and the ultrasound source (p.002) were statistically linked to failure. No complications were recorded. This is the largest series of OO treated using MRgFUS even reported. The main strength of this study lies in its large sample size and the extended follow-up period for nearly all patients (4 years for 90 % of patients) which allow us to clearly confirm the safety and efficacy of this ablative technique. Moreover, exclusion criteria for this treatment modality are proposed, based on two causes of treatment failure identified during our procedures.

Indexed as

BoneMagnetic Resonance-guided Focused Ultrasound SurgeryMRgFUSOsteoid OsteomaThermal ablation

Identifiers

PMID41341895
PMCPMC12670571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.